Covering Up The Causes of Breast Cancer Since 1985: AstraZeneca’s BCAM

by Sayer Ji
GreenMedInfo.com

Did you know that AstraZeneca, manufacturer of two blockbuster breast cancer drugs (one of which is classified as a known human carcinogen), is behind Breast Cancer Awareness Month?

Why is it, do you think, that during Breast Cancer Awareness Month (BCAM) you never hear the word “carcinogen” mentioned, but are barraged a million times over by the word “cure”?

Truth be told, BCAM should be renamed Breast Cancer Un-Awareness Month, as it has nothing to do with generating awareness about the true causes and solutions for the breast cancer epidemic and everything to do with making the public focus on a presumably not-yet-existent “cure” to be produced through the pharmaceutical pipeline somewhere off in the future only after enough money is raised.

Instead of identifying and addressing the known causes of cancer, like the many mammary carcinogens now identified in body care products,GMO and processed foods, and our polluted environment, the mission of BCAM is to make people think that the best way to prevent breast cancer is to “detect it early.”

And how?

By subjecting their breasts to radiation-based diagnostic screening that we now know actually causes breast cancer, and which has lead to over one million cases of falsely diagnosed and unnecessarily treated breast cancers in the past 30 years in U.S. women alone. One recent review on the topic of mammography concluded that they are harmful and should be avoided, and yet you will hear countless messages this month that breast screenings are safe and effective for reducing breast cancer mortality — technically, a lie.

This viral meme describes the underlying agenda succinctly:

Back in 2012, when we first wrote “The Dark Side of Breast Cancer [Un]Awareness Month,” in order to shed light on this travesty, the real history of Breast Cancer Awareness Month’s origins was still relatively unknown despite the fact that it was a matter of public record. According to the Wikipedia page on the topic:

“NBCAM was founded in 1985 as a partnership between the American Cancer Society and the pharmaceutical division of Imperial Chemical Industries (now part of AstraZeneca, maker of several anti-breast cancer drugs). The aim of the NBCAM from the start has been to promote mammography as the most effective weapon in the fight against breast cancer.”

The reference link listed on Wikipedia for the paragraph above comes from the BCAM website, but is now dead. For reasons that remain a mystery, the BCAM website was taken offline by AstraZeneca in the intervening years. Despite this, the BCAM domain name — www.nbcam.org — still links directly to AtraZeneca’s HealthCare Foundation page; astounding evidence that AstraZeneca owned and controlled BCAM and still does. You can still view the WayBackMachine’s archived NBCAM website here if you are curious.

And so why is this connection so important? 

What is so disturbing about AstraZeneca’s founding role in BCAM is that it “just happens” to make two blockbuster breast cancer drugs, Tamoxifen and Arimidex — a conflict of interest so flagrant, its hard to ignore. Even more disturbing is that Tamoxifen is actually classified by the International Agency for Research on Cancer as a known human carcinogen! A carcinogenic “treatment” for breast cancer?  No wonder BCAM won’t allow the word “carcinogen” mentioned in any of its campaigns. 

Back when AstraZeneca kept the BCAM website functioning, it was easy to prove how BCAM and AstraZeneca had pinkwashed the concept of the true causes of cancer (carcinogens) from the public mind. You used to be able to plop the word “carcinogen” into the site’s search engine feature and you would retrieve the following highly suspect results:

Your search – carcinogen – did not match any documents. No pages were found containing “carcinogen”.

Likewise, back in 2012, on Susan G. Komen’s website, the term “carcinogen” only emerged twice, and both in the context of denying the likelihood of there being a connection between smoking and breast cancer. If you search the site today, the term has been further scrubbed, with no informative results retrieved with the term.

Clearly this is strategic. There are literally thousands of possible and known carcinogens identified in various public databases, such as Toxnet.gov. Roundup herbicide, for instance, was recently reclassified as a probable carcinogen by the World Health Organization. If the goal is really to protect women and reduce breast cancer morbidity and mortality, shouldn’t Breast Cancer Awareness Month focus on identifying and reducing exposure to probable and/or known carcinogens?  Failing to do so is equivalent to deceit, if not malfeasance, is it not?

This all makes greater sense when you understand the history behind BCAM’s founder AstraZeneca. AstraZeneca was formed through the merger of Astra AB and Zeneca Group (a pharmaceutical subsidiary of Imperial Chemical Industries) in 1999. Imperial Chemical Industries, a multinational corporation responsible for producing breast cancer causing petrochemical derivatives such as vinyl chloride and pesticides, founded National Breast Cancer Awareness Month in 1985, in partnership with the American Cancer Society, in order to promote the widespread adoption of x-ray mammography, whose failings if not horrors we have documented extensively elsewhere.

This means the very corporation that contributed significantly to accelerating the breast cancer epidemic also profited and still profits from new diagnoses of breast cancer and their treatment.

Sadly, Breast Cancer Awareness Month is a time of increasing awareness not of the preventable causes of breast cancer, but of the breast cancer industry’s insatiable need to both raise money for research into a would-be “pharmaceutical cure,” and to promote its primary means of “prevention”: early detection via x-ray mammography.’It’s also a cause-marketing feeding frenzy with a disturbingly vast array of carcinogen-containing products sporting Susan G. Komen’s pink ribbon, presumably “in support” of raising awareness, including the hot pink fracking drill bit pictured above.

The Truth About Cancer. Click here to view this documentary.

Please, before you consider going on a march, donating to the “cause,” or buying a pink-ribbon-bedecked product this month, consider the true origins of the year’s most widespread brainwashing event. For real information on the real causes and solutions for cancer watch the upcoming Truth about Cancer documentary series, of which I will be a part. It promises to be the much needed antidote to the propaganda that has spread as viciously as cancer itself. You can also use our Cancer Research database with thousands of articles and study abstracts on treating cancer naturally.

Finally, please share the meme below (save to desktop and re-upload to Facebook and other social media platforms), with the link to this article: http://tinyurl.com/pinkwashed.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of GreenMedInfo or its staff.

Read the full article at GreenMedInfo.com

We Lost the War on Cancer – Review of Alternative Cancer Therapies

eBook
Retail : $9⁹⁹
Now : $5⁹⁹

We have lost the war on cancer. At the beginning of the last century, one person in twenty would get cancer. In the 1940s it was one out of every sixteen people. In the 1970s it was one person out of ten. Today one person out of three gets cancer in the course of their life.

The cancer industry is probably the most prosperous business in the United States. In 2014, there will be an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the US. $6 billion of tax-payer funds are cycled through various federal agencies for cancer research, such as the National Cancer Institute (NCI). The NCI states that the medical costs of cancer care are $125 billion, with a projected 39 percent increase to $173 billion by 2020.

The simple fact is that the cancer industry employs too many people and produces too much income to allow a cure to be found. All of the current research on cancer drugs is based on the premise that the cancer market will grow, not shrink.

John Thomas explains to us why the current cancer industry prospers while treating cancer, but cannot afford to cure it in Part I. In Part II, he surveys the various alternative cancer therapies that have been proven effective, but that are not approved by the FDA.